Beste apotheek van Nederland

Gleave M, Qian J, Andreou C et al. The effects of the dual 5areductase
inhibitor dutasteride on localized prostate cancer -
Results from a 4-month pre-radical prostatectomy study.
Prostate Suppl 2006;66(15):1674-1685.
Glick H A, McCarron T J, Althof S E et al. Construction of
scales for the Center for Marital and Sexual Health (CMASH)
Sexual Functioning Questionnaire. J Sex Marital Ther
1997;23(2):103-117.
Glimelius B, Steineck G. Low evidence of radiation therapy in
prostate cancer: A plea for intensified scientific activity. Acta
Oncol (Madr) 2004;43(4):311-315.
Glina S. Testosterone and erectile dysfunction. The Journal of
Mens Health & Gender 2004;1(4):407-412.
Glina S, Silva M F, Puech-Leao P et al. Veno-occlusive
dysfunction of corpora cavernosa: comparison of diagnostic
methods. Int J Impot Res 1995;7(1):1-10.
Goadsby P J. Recent advances in the diagnosis and management
of migraine. Br Med J 2006;332(7532):25-29.
Godschalk M F, Unice K A, Bergner D et al. A trial study: The
effect of low dose human chorionic gonadotropin on the
symptoms of benign prostatic hyperplasia. Br J Urol 2003;170(4
I):1264-1269.
Goetz L L, Stiens S A. Abdominal electric stimulation facilitates
penile vibratory stimulation for ejaculation after spinal cord
injury: a single-subject trial. Archives of Physical Medicine &
Rehabilitation 2005;86(9):1879-1883.
Review.
Alboni P, Bettiol K, Fuca G et al. Sexual activity with and
without the use of sildenafil: risk of cardiovascular events in
patients with heart disease. [Review] [41 refs]. Italian Heart
Journal: Official Journal of the Italian Federation of Cardiology
2004;5(5):343-349.
Alexander W D. The diabetes physician and an assessment and
treatment programme for male erectile impotence. Diabet Med
1990;7(6):540-543.
Althof Stanley E, Seftel Allen D. The evaluation and
management of erectile dysfunction. Psychiatr Clin North Am
1995;18(1):171-192.
Altwein J E, Thon W F. Oral treatment of erectile dysfunction:
Background, spectrum and limitations. Aktuel Urol
1999;30(7):449-460.
Anderson P C B, Gommersall L, Hayne D et al. New
phosphodiesterase inhibitors in the treatment of erectile
dysfunction. Expert Opin Pharmacother 2004;5(11):2241-2249.
Anderson T R, Goldberg J F, Harrow M. A review of
medication side effects and treatment adherence in bipolar
disorder. Primary Psychiatry 2004;11(9):48-54.
Andersson K-E, Schroder A. Therapeutic strategies for
drug treatment of stress urinary incontinence. Drug
Discovery Today: Therapeutic Strategies
2004;1(2):259-265.
Anonymous. New oral drugs for erectile dysfunction.
[Review] [21 refs]. Drug & Therapeutics Bulletin
2004;42(7):49-52.
Anonymous. Oral agents are successful in the
treatment of erectile dysfunction in patients with
cardiovascular disease. Drugs & Therapy Perspectives
2005;21(6):
Anonymous. Phosphodiesterase type 5 (PDE5)
inhibitors: Looking beyond erectile dysfunction.
British Journal of Cardiology 2003;10(SUPPL. 4):S1­
S8.
Anonymous. In erectile disorders: A narrow
therapeutic margin. Prescrire Int 2002;11(59):76-79.
Anonymous. Tadalafil. Slightly more convenient, but
poorly assessed in organic disorders. Prescrire Int
2003;12(68):213-215.
Anonymous. Sildenafil and erectile dysfunction.
Helpful. Prescrire Int 1998;7(38):163-165.
Archer S L, Gragasin F S, Webster L et al. Aetiology
and management of male erectile dysfunction and
female sexual dysfunction in patients with
cardiovascular disease. Drugs Aging 2005;22(10):823­
844.
Ashton A K, D'Mello D A, Dantz B et al. Treatment
regimens for managing depression in family practice. J
Fam Pract 2003;52(SUPPL.):S48-S60.
Atala A, Amin M. Current concepts in the treatment of
genitourinary tract disorders in the older individual.
[Review] [87 refs]. Drugs Aging 1991;1(3):176-193.
Aung H H, Dey L, Rand V et al. Alternative therapies
for male and female sexual dysfunction. Am J Chin
Med 2004;32(2):161-173.
Aversa A, Bruzziches R, Spera G. A rationale for the
use of testosterone 'salvage' in treatment of men with
erectile dysfunction failing phosphodiesterase
inhibitors. Endocr Pract 2005;15(2):99-105.
Aversa A, Pili M, Fabbri A et al. Erectile dysfunction:
Expectations beyond phosphodiesterase Type 5
inhibition. J Endocrinol Invest 2004;27(2):192-206.
Bain J. Epidemiology, evaluation and diagnosis of
andropause. Geriatrics and Aging 2003;6(10
SUPPL.):4-8.
D-37